Home Capital Results

Hyphens Pharma 2Q19 earnings up 1.4% to $1.64 mil on lower expenses

Uma Devi
Uma Devi8/13/2019 07:44 PM GMT+08  • 2 min read
Hyphens Pharma 2Q19 earnings up 1.4% to $1.64 mil on lower expenses
Group revenue for the quarter fell 6.1% to $29 million from $30.9 million the preceding year,  due primarily to a decline of 14.1% in the specialty pharma principals segment in 2Q19 on the back of higher demand in 2Q18, ahead of products licensing renewa
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Aug 13): Hyphens Pharma International reported 2Q19 earnings of $1.6 million, up 1.4% from $1.61 million for the same quarter last year.

Earnings per share for 2Q19 fell to 0.54 cent from 0.63 cent in 2Q18.

Group revenue for the quarter fell 6.1% to $29 million from $30.9 million the preceding year, due primarily to a decline of 14.1% in the specialty pharma principals segment in 2Q19 on the back of higher demand in 2Q18, ahead of products licensing renewal in Vietnam.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now